2015
DOI: 10.1007/s00726-015-1986-1
|View full text |Cite
|
Sign up to set email alerts
|

A review and discussion of platelet nitric oxide and nitric oxide synthase: do blood platelets produce nitric oxide from l-arginine or nitrite?

Abstract: The NO/sGC/cGMP/PKG system is one of the most powerful mechanisms responsible for platelet inhibition. In numerous publications, expression of functional NO synthase (NOS) in human and mouse platelets has been reported. Constitutive and inducible NOS isoforms convert L-arginine to NO and L-citrulline. The importance of this pathway in platelets and in endothelial cells for the regulation of platelet function is discussed since decades. However, there are serious doubts in the literature concerning both express… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
37
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 57 publications
(38 citation statements)
references
References 117 publications
1
37
0
Order By: Relevance
“…The research was performed in a hyperbaric chamber to eliminate the effect of physical activity and the temperature of the aquatic environment. In addition, biochemical analysis was performed on natriuretic peptides (BNP and ANP) involved in the regulation of haemodynamic circulation [1619] and vasoconstriction (urotensin II) [20]; the level of the endogenic amino acid and the nitrogen oxide precursor (L-arginine) [21–23]; and measurement of parameters involved in cardiac remodeling (angiotensin II and angiotensin (1–7)) [2428]. …”
Section: Introductionmentioning
confidence: 99%
“…The research was performed in a hyperbaric chamber to eliminate the effect of physical activity and the temperature of the aquatic environment. In addition, biochemical analysis was performed on natriuretic peptides (BNP and ANP) involved in the regulation of haemodynamic circulation [1619] and vasoconstriction (urotensin II) [20]; the level of the endogenic amino acid and the nitrogen oxide precursor (L-arginine) [21–23]; and measurement of parameters involved in cardiac remodeling (angiotensin II and angiotensin (1–7)) [2428]. …”
Section: Introductionmentioning
confidence: 99%
“…A similar mechanism involving decreased eNOS activity may play a role in medial thickening and vascular dropout in SSc_related secondary RP . Additionally, nitric oxide is a potent inhibitor of platelet aggregation . Impairment in this functionality likely contributes to pathologic platelet aggregation that contributes to capillary thrombosis in SSc…”
Section: Role Of No In Secondary Rp and Systemic Sclerosismentioning
confidence: 99%
“…The expression and function of two NOS isoforms, eNOS and iNOS, have been reported in platelets; however, their activity and regulation are controversial (reviewed in [249]). NO produced by endothelial cells or by platelets, inhibits platelet adhesion, aggregation, recruitment, and formation of leukocyte-platelet aggregates.…”
Section: Role Of Platelets In Vascular Tone Regulation: Effects Omentioning
confidence: 99%